A detailed history of State Of Wyoming transactions in Organon & Co. stock. As of the latest transaction made, State Of Wyoming holds 11,259 shares of OGN stock, worth $182,170. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,259
Holding current value
$182,170
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $209,980 - $259,294
11,259 New
11,259 $215,000
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $61,031 - $83,265
4,429 Added 65.17%
11,225 $211,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $29,904 - $47,300
2,731 Added 67.18%
6,796 $97,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $22,462 - $32,184
-1,354 Reduced 24.99%
4,065 $70,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $22,873 - $29,235
1,187 Added 28.05%
5,419 $112,000
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $90,649 - $135,762
4,232 New
4,232 $99,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $76,892 - $112,545
3,286 Added 328600.0%
3,287 $77,000
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $90,610 - $111,331
-2,862 Reduced 99.97%
1 $0
Q1 2022

May 13, 2022

BUY
$30.45 - $39.36 $49,389 - $63,841
1,622 Added 130.7%
2,863 $100,000
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $44,266 - $57,328
-1,544 Reduced 55.44%
1,241 $38,000
Q3 2021

Feb 14, 2022

BUY
$28.63 - $35.64 $79,734 - $99,257
2,785 New
2,785 $91,000
Q3 2021

Feb 11, 2022

SELL
$28.63 - $35.64 $4,523 - $5,631
-158 Closed
0 $0
Q2 2021

Feb 14, 2022

BUY
$28.45 - $38.0 $4,495 - $6,004
158 New
158 $5,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.12B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.